Navigation Links
Prominent 'Chick Lit' Novelist Laura Zigman Joins HealthCentral's MyBreastCancerNetwork.com as Expert
Date:10/31/2007

ARLINGTON, Va., Oct. 31 /PRNewswire-USNewswire/ -- The HealthCentral Network, Inc. (http://www.HealthCentral.com) today announced that breast cancer survivor Laura Zigman, a best-selling author regarded as the progenitor of the "Chick Lit" genre, will join MyBreastCancerNetwork.com as an expert.

Zigman's weekly blogs will approach breast cancer from the everyday woman's point of view, with the goal of making life with cancer approachable and, at times, even funny. The 45-year-old novelist will regularly appear as a comic strip character in her blog, living out her cancer experience in a bright, visual format.

Zigman's graphic blogs will combine the visual impact of graphic novels like Cancer Vixen with the near-instant gratification of Zigman herself responding to comments from the community. Her responsiveness in the social networking sphere was featured recently in the New York Times Sunday Book Review, with the author using her MySpace page to interact with her readers in "den mother" fashion.

Zigman's refreshing and supportive responsiveness will add to an already vibrant network of experts and community members who share their personal stories of living with an often life-changing condition. MyBreastCancerNetwork.com also provides targeted clinical information and resources on treating and managing the condition.

"Those who have breast cancer are desperate to know the truth about what to expect," Zigman said. " I'm thrilled to have a chance to be a part of MyBreastCancerNetwork.com -- a site I wish I had known about last year for the depth of information as well as for the sense of community -- because it's where you will hear the truth."

"Laura Zigman's work supporting breast cancer sufferers and survivors makes her an excellent addition to the HealthCentral team," said Chris Schroeder, CEO and President of The HealthCentral Network. "Laura's expertise and dedica
'/>"/>

SOURCE The HealthCentral Network
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New Study In Australia Shows Heart Disease More Prominent Among The Poor
2. Medical intervention , a prominent cause of emergency caesarians
3. Jolies Slimmer Arms Shows Her Prominent Veins
4. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
5. Vaccine To Stop the Spread of Chickenpox
6. Chickens Found To Have High Levels of Arsenic
7. The Effectiveness Of Chickenpox Vaccine Questioned
8. Chicken-Pox vaccine not fool proof
9. Chicken pox beholds brain tumour risk
10. Super Bugs Contaminate UK Chickens
11. Chicken Pox Hospitalizations Are Becoming Less

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...tudy finds gene variation believed to affect circa...ealthDay News) -- New research suggests that an in...a factor in the development of bipolar disorder in...ination of the genetic makeup of 152 children with...le to major mood swings, and 140 children without ...
(Date:11/27/2009)... Biotech firm Replikins Lt... the H1N1 virus genomic data. It shows that the l... 3.7 (s.d. 4.5) during the virus,s current outbrea...vels this week of 2.0 (s.d. 0.1). The H1N1 infecti... Boston (PRWEB) November 27, 2009 ...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /P...erican professional cycling team dedicated to ethi... cycling champions, announced today that it will b... Transitions Optical as a new sponsor of the team....cturer of adaptive eyewear, offering the most adva...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Specialist manufacturers ...roducts are saving millions of dollars by bringing... process. Increasing numbers of pro-active medical...perts at the concept stage of their projects, ensu...ting design processes or potentially outdated tech...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...archers at the Harvard Medical School it is said t... chronically infected cystic fibrosis (CF) patient...which secretes proteins that cause disease in the ...ay be a cancer patient with a weakened immune syst...
...on placed new restrictions on a doctors’ role i...st any policy //that gives medical professionals ...to use harsher tactics than they would in the abs...roups and medical ethicists. They charge that doct...
...ar excuse "not tonight, I have a headache," a new ...xual activity and says that sexual desire and migr... // In fact, migraine sufferers reported hig...eagues. 'Migraine patients in general may exp...
...lthcare products Regulatory Agency (MHRA) warned t...eadings. The diabetic patients are cautioned about...d to giving readings which were far too high. Diab...nsulin resulting in hypoglycaemic coma. It is...
...in San Diego, California, Allerca, Inc., is now t...kitten, the world’s first hypoallergenic cats //.T...o are also cat lovers. Allerca sources claim ...ng. Hence these animals were not transgenic,in oth...
...s at the Johns Hopkins Bloomberg School of Public ...lar immune tactics to ward off bacterial// pathoge...wn on the different genes connected with the prote...rtant for the resistance to bacterial infection. H...
Other Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:What Ticks the Mosquito immune system? 2
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Mammography Equipm...www.reportlinker.com/p0164330/Mammography-Equipmen... incidence of breast cancer in industrialized as w...fluencing growth in the mammography market. Global...
(Date:11/25/2009)...EL HILL, N.C., Nov. 25 Cempra Phar...Fernandes, president and chief executive officer, ...th Care Conference at 8:50 a.m. EST, December 1, 2.... Dr. Fernandes will provide an overview of the c...for the treatment of drug-resistant pathogens incl...
(Date:11/25/2009)...VIEW, Calif., Nov. 25 ChemoCentr...al data from the Company,s PROTECT-1 (the Prospect...disease Trial) of Traficet-EN(TM) (CCX282-B) in pa...onstrated clinical efficacy with a favorable safet...d evidence of clinical efficacy in the reduction o...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Are breast cancer patients being kept in the dark 3F 50933 1Are breast cancer patients being kept in the dark 3F 50933 2One step closer to an artificial nerve cell 50931 1One step closer to an artificial nerve cell 50931 2Severe COPD may lead to cognitive impairment 50929 1Severe COPD may lead to cognitive impairment 50929 2Severe COPD may lead to cognitive impairment 50929 3
..." Study Also Showed Arzoxifene Significantly Suppr...ostmenopausal Women with Osteoporosis , , ATHENS,...LLY ) presented new data showing arzoxifene, an in...r (SERM), was superior to raloxifene at increasing...otal hip and femoral neck, and at suppressing bone...
...20 Santaris Pharma announced today that,the fourt... In the USA,several patients with cancer have now ..., which is jointly developed by Santaris Pharma an...ministration (FDA) recently,accepted Enzon PharmaÂ...tion,for the use of the LNA-based Survivin inhibit...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: